SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Grwth Regulatory News (CMPG)

Share Price Information for Ct Global Grwth (CMPG)

Share Price is delayed by 15 minutes
Get Live Data
323.00    0.00 (0.00%)
Bid:
320.00
Ask:
326.00
Spread: 6.00 (1.875%)
Market Cap: £306.89m
CMPG Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Grwth Share Chart

Directorate change

19 Feb 2026 11:08

RNS Number : 7012T
CT Global Managed Portfolio Trust
19 February 2026
 

To: RNS

From: CT Global Managed Portfolio Trust PLC

Date: 19 February 2026

LEI: 213800ZA6TW45NM9YY31

 

 

CT Global Managed Portfolio Trust PLC ('the Company')

 

Directorate Change

 

Appointment of Non-Executive Director and Chair of the Marketing Committee

Information disclosed in accordance with paragraph 6.4.6R of the Financial Conduct Authority's UK Listing Rules.

 

Following a formal recruitment process and a search conducted by an independent agency, the Board of the Company is pleased to announce the appointment of Roland Spencer as a non-executive director of the Company with effect from 19 February 2026. From this date, Roland will also chair the Marketing Committee, in place of David Warnock.

 

Roland has twenty-five years' experience in the financial sector, including eighteen years in the UK direct‑to‑consumer investments and platform market. His most recent role was Head of New Business at AJ Bell where he previously held a number of senior positions covering AJ Bell Media, corporate development, marketing and product proposition between 2012 to 2025. A recognised industry expert, Roland is a regular speaker at events on retail investor engagement.

 

Roland Spencer, and his Persons Closely Associated to him, do not own any Income shares or Growth shares in the Company and his election will be proposed to shareholders for approval at the Annual General Meeting of the Company currently scheduled to be held in September 2026.

 

There is no other information required to be disclosed pursuant to paragraph 6.4.8R of the Financial Conduct Authority's UK Listing Rules in relation to this appointment.

 

David Warnock, Chairman commented:

 

'We are delighted to welcome Roland as a non-executive director of the Company and believe that his experience of marketing, the direct-to-consumer market and retail investor engagement will add considerable value to the Board.'

 

 

For further information contact:

 

Ian Ridge

Columbia Threadneedle Investment Business Limited

Company Secretary

 

Tel: 0131 573 8300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPURUPUPQGGB
Date   Source Headline
12th Jun 202612:30 pmRNSNet Asset Value(s)
11th Jun 202612:50 pmRNSNet Asset Value(s)
10th Jun 202612:35 pmRNSNet Asset Value(s)
9th Jun 202612:32 pmRNSNet Asset Value(s)
8th Jun 20264:42 pmRNSIssue of Equity
8th Jun 202612:36 pmRNSNet Asset Value(s)
5th Jun 20261:01 pmRNSNet Asset Value(s)
5th Jun 202612:24 pmRNSPortfolio Update
4th Jun 202612:32 pmRNSNet Asset Value(s)
3rd Jun 202612:39 pmRNSNet Asset Value(s)
2nd Jun 202612:48 pmRNSNet Asset Value(s)
1st Jun 20263:15 pmRNSCompliance with Market Abuse Regulation
1st Jun 202612:44 pmRNSNet Asset Value(s)
1st Jun 202611:08 amRNSTotal Voting Rights
29th May 20265:39 pmRNSTransaction in Own Shares and Issue of Equity
29th May 202612:43 pmRNSNet Asset Value(s)
28th May 202612:50 pmRNSNet Asset Value(s)
27th May 202612:50 pmRNSNet Asset Value(s)
26th May 202612:47 pmRNSNet Asset Value(s)
22nd May 20264:00 pmRNSIssue of Equity
22nd May 20261:35 pmRNSPortfolio Update
22nd May 202612:53 pmRNSNet Asset Value(s)
21st May 202612:54 pmRNSNet Asset Value(s)
20th May 202612:49 pmRNSNet Asset Value(s)
19th May 202612:48 pmRNSNet Asset Value(s)
18th May 20261:47 pmRNSNet Asset Value(s)
15th May 202612:50 pmRNSNet Asset Value(s)
14th May 20265:05 pmRNSIssue of Equity
14th May 202612:47 pmRNSNet Asset Value(s)
13th May 202612:32 pmRNSNet Asset Value(s)
12th May 202612:46 pmRNSNet Asset Value(s)
11th May 20261:13 pmRNSNet Asset Value(s)
8th May 202612:53 pmRNSNet Asset Value(s)
7th May 20265:18 pmRNSTransaction in Own Shares
7th May 202612:42 pmRNSNet Asset Value(s)
6th May 202612:52 pmRNSNet Asset Value(s)
5th May 202612:54 pmRNSNet Asset Value(s)
1st May 20261:01 pmRNSNet Asset Value(s)
1st May 202611:36 amRNSTotal Voting Rights
30th Apr 20264:00 pmRNSIssue of Equity
30th Apr 202612:29 pmRNSNet Asset Value(s)
29th Apr 20264:22 pmRNSIssue of Equity
29th Apr 202612:50 pmRNSNet Asset Value(s)
28th Apr 202612:49 pmRNSNet Asset Value(s)
27th Apr 202612:45 pmRNSNet Asset Value(s)
24th Apr 202612:51 pmRNSNet Asset Value(s)
23rd Apr 20264:43 pmRNSIssue of Equity
23rd Apr 20262:16 pmRNSPortfolio Update
23rd Apr 202612:36 pmRNSNet Asset Value(s)
22nd Apr 202612:50 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.